(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 98.28%-30.36K | 39.17%-523.98K | 39.54%-905.4K | -33.86%-4.34M | 72.32%-223.52K | -70.27%-1.76M | -21.18%-861.32K | -116.36%-1.5M | 40.22%-3.24M | 5.32%-807.41K |
Net income from continuing operations | 61.35%-612.06K | 7.16%-1M | 24.59%-750.62K | -34.88%-5.48M | -45.14%-1.82M | -21.29%-1.58M | -25.12%-1.08M | -55.60%-995.38K | 34.11%-4.06M | -53.15%-1.26M |
Asset impairment expenditure | ---- | ---- | ---- | --795.53K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --188.54K | --187.04K | 1,048.58%182.45K | -26.79%286.22K | 757.95%270.33K | --0 | --0 | --15.89K | -36.61%390.94K | 159.28%31.51K |
Change In working capital | 322.59%393.16K | 33.83%289.25K | 34.90%-337.23K | -87.16%54.85K | 27.93%533.37K | -101.72%-176.63K | 43.78%216.13K | -888.04%-518.02K | 251.41%427.24K | 1,946.62%416.92K |
-Change in receivables | -659.88%-9.95K | -98.18%1.25K | 95.73%-8.42K | -24.03%29.68K | 1,627.00%156.52K | 104.73%1.78K | -35.74%68.68K | -889.02%-197.29K | -81.35%39.07K | -121.66%-10.25K |
-Change in payables and accrued expense | 325.95%403.11K | 95.32%288.01K | -2.52%-328.81K | -93.52%25.16K | -11.78%376.85K | -257.08%-178.41K | 239.38%147.45K | -887.44%-320.73K | 541.41%388.17K | 1,684.92%427.17K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 98.28%-30.36K | 39.17%-523.98K | 39.54%-905.4K | -33.86%-4.34M | 72.32%-223.52K | -70.27%-1.76M | -21.18%-861.32K | -116.36%-1.5M | 40.22%-3.24M | 5.32%-807.41K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 65.69%-81.76K | -385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | 0 | 14.14%-745.42K | 24.48%-571.59K |
Net PPE purchase and sale | --0 | 65.69%-81.76K | ---385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | --0 | 14.14%-745.42K | 24.48%-571.59K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 65.69%-81.76K | ---385.58K | 54.80%-336.95K | 93.41%-37.65K | -35.57%-60.97K | -120.88%-238.32K | --0 | 14.14%-745.42K | 24.48%-571.59K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 103.96K | -60.58%1.85M | 4.68M | 0 | 0 | 0 | 4.68M | 0 | 0 |
Net common stock issuance | --0 | --110K | -60.20%1.99M | --5M | --0 | --0 | --0 | --5M | --0 | --0 |
Net other financing activities | --0 | ---6.04K | 54.62%-144.7K | ---318.85K | --0 | --0 | --0 | ---318.85K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --103.96K | -60.58%1.85M | --4.68M | --0 | --0 | --0 | --4.68M | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -96.45%74.71K | -82.01%576.49K | 7.30%22.17K | -99.48%20.66K | -79.76%283.35K | -15.08%2.1M | -2.82%3.2M | -99.48%20.66K | -59.92%4.01M | -75.09%1.4M |
Current changes in cash | 98.33%-30.36K | 54.37%-501.78K | -82.59%554.32K | 100.04%1.51K | 81.06%-261.18K | -68.83%-1.82M | -34.32%-1.1M | 546.45%3.18M | 33.46%-3.99M | 14.33%-1.38M |
End cash Position | -84.35%44.35K | -96.45%74.71K | -82.01%576.49K | 7.30%22.17K | 7.30%22.17K | -79.76%283.35K | -15.08%2.1M | -2.82%3.2M | -99.48%20.66K | -99.48%20.66K |
Free cash from | 98.33%-30.36K | 44.91%-605.74K | 13.79%-1.29M | -17.30%-4.68M | 81.06%-261.18K | -68.83%-1.82M | -34.32%-1.1M | -110.00%-1.5M | 36.63%-3.99M | 14.33%-1.38M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data